Results from the first randomized controlled trial to directly compare the safety and efficacy of cutting balloon (CB) angioplasty to intravascular lithotripsy (IVL) prior to drug-eluting stent (DES) ...

SAN FRANCISCO – OCTOBER 26, 2025 – New study findings show that utilizing super-high-pressure non-compliant balloons (NCB) is non-inferior to intravascular lithotripsy (IVL) balloon catheters for ...

SAN FRANCISCO – OCTOBER 26, 2025 – Results from the first randomized controlled trial to directly compare the safety and efficacy of cutting balloon (CB) angioplasty to intravascular lithotripsy (IVL) ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Typical balloon placement and pretreatment sites relative to pacing/defibrillation leads. Photo Credit: J Am Coll Cardiol EP. Central Illustration (adapted). Pacemaker and defibrillator leads encased ...

SANTA CLARA, Calif., June 28, 2021 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified ...

UAB St. Vincent’s, part of the University of Alabama at Birmingham Health System, is the first hospital in the Greater Birmingham area where cardiologists have performed an innovative new treatment ...

WASHINGTON, DC — Atherectomy has no advantage over conventional balloon angioplasty for the treatment of severe calcified lesions, according to unexpected results from the largest trial of the ...

Abbott will be trying its hand in the growing field of intravascular lithotripsy, with a clinical study to examine an unnamed, investigational system that aims to fracture hardened calcium within the ...

Add Yahoo as a preferred source to see more of our stories on Google. With Shockwave, J&J gained a fast-growing treatment for coronary artery disease, which is the most common form of heart disease.